NCT02008461

Botulinum Toxin Injection for Preventing Secondary Atrial Fibrillation in Patient With Supra-ventricular Tachyarrythmias

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Meshalkin Research Institute of Pathology of Circulation · Network
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The investigators have conducted a prospective, double-blind, randomized study to assess the comparative safety and efficacy of two different ablation strategies, RFA versus RFA plus botulinum toxin injection, in patients with supra-ventricular tachyarrhythmias. Results were assessed with the use of an implanted monitoring device (IMD).

Conditions

• Supra-ventricular Tachyarrhythmias

Interventions

Type	Name	Description
PROCEDURE	radiofrequency ablation
DRUG	botulinum toxin injection

Timeline

• Start date: 2013-06-01
• Primary completion: 2015-12-01
• Completion: 2016-02-01
• First posted: 2013-12-11
• Last updated: 2015-09-23

Locations

2 sites across 2 countries: United States, Russia